Building Bridges – Collaboration between Science, SMEs, and Big Pharma

“Building Bridges – Collaboration between Science, SMEs, and Big Pharma”

How can successful cooperation between academic research, small and medium-sized enterprises, and global pharmaceutical companies be achieved?

We are pleased to welcome Ralf Angermund, Director of Early Innovation Partnering Germany at @Johnson & Johnson Innovative Medicine, who will share valuable insights into:

• effective collaboration strategies
• key success factors
• challenges at the interface of science and industry

🗓 Date: 13 January 2026
🕐 Time: 13:00 – 14:00 CET
📍 Location: CRTD, Auditorium Dresden (Fetscherstraße 105, 01307 Dresden, Germany)
💻 Format: Hybrid (on-site & online)

Whether you are from academia, a startup, or industry, this lecture offers an excellent opportunity to gain perspectives on building strong, sustainable innovation partnerships.

👉 On-site: CRTD Auditorium Dresden
👉 Online: https://shorturl.at/GCwOa